SCHEMBL10074444

SCHEMBL10074444

CN1CCN(Cc2ccc(C(=O)OCc3ccc(C(=O)O)cc3)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHKA P35790 2/20 0.57
HDAC6 Q9UBN7 2/20 0.56
NPC1 O15118 1/20 0.51
TP53 P04637 1/20 0.51
RAB9A P51151 1/20 0.51
HRH3 Q9Y5N1 3/20 0.50
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
MC4R P32245 1/20 0.49
LMNA P02545 5/20 0.47
POLB P06746 1/20 0.47
ALDH1A1 P00352 1/20 0.47
MAPK1 P28482 1/20 0.46
GAA P10253 1/20 0.46
THRB P10828 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
BTK Q06187 1/20 0.46
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14689861 0.92 NPC1 (0.61) CHKAHDAC6NPC1TP53RAB9A
SCHEMBL16356429 0.87 HDAC6 (0.69) CHKAHDAC6NPC1TP53RAB9A
SCHEMBL65179 0.87 HDAC6 (0.69) CHKAHDAC6NPC1TP53RAB9A
SCHEMBL14689926 0.87 CHKA (0.58) CHKAHDAC6NPC1TP53RAB9A
Hydrochloric Acid SCHEMBL3272318 0.86 HDAC6 (0.68) CHKAHDAC6HRH3MEN1KMT2A
Hydrochloric Acid SCHEMBL846616 0.86 HDAC6 (0.68) CHKAHDAC6HRH3MEN1KMT2A
Hydrochloric Acid SCHEMBL14763998 0.86 HDAC6 (0.68) CHKAHDAC6HRH3MEN1KMT2A
Hydrogen Sulfide SCHEMBL27950422 0.85 HDAC6 (0.62) CHKAHDAC6NPC1TP53RAB9A
Hydrochloric Acid SCHEMBL3664891 0.84 HDAC6 (0.66) CHKAHDAC6HRH3MEN1KMT2A
Hydrochloric Acid SCHEMBL1583152 0.84 HDAC6 (0.66) CHKAHDAC6HRH3MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130203990-A1 PROCESS FOR THE PREPARATION OF IMATINIB MESYLATE DR. REDDY'S LABORATORIES, INC. (US) 2013-08-08 US disclosed
US-20130203990-A1 PROCESS FOR THE PREPARATION OF IMATINIB MESYLATE DR. REDDY'S LABORATORIES, INC. (US) 2013-08-08 US disclosed
WO-2013008242-A1 A PROCESS FOR THE PREPARATION OF HIGHLY PURE 4-(4-METHYL PIPERAZINOMETHYL) BENZOIC ACID DIHYDROCHLORIDE NATCO PHARMA LIMITED (IN) 2013-01-17 WO disclosed
WO-2012015999-A2 PROCESS FOR THE PREPARATION OF IMATINIB MESYLATE DR. REDDY'S LABORATORIES LTD. (IN) 2012-02-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130203990-A1 PROCESS FOR THE PREPARATION OF IMATINIB MESYLATE ABL1, ABL2, PDGFRA CHKA 1893/4885HDAC6 4050/4885NPC1 3354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.